Overactive Bladder - Results from #340

Quality of life and psychological aspects in children with overactive bladder treated with parasacral transcutaneous electrical nerve stimulation - A prospective multicenter study. November 13, 2022

Bullseye Technique to Optimize S3 Foramen Access: Applying a Trusted Endourology Technique to Pelvic Medicine. November 13, 2022

Efficacy and safety of combination of mirabegron and solifenacin in patients with double-J stent related overactive bladder: a prospective study. November 13, 2022

Evaluation of Overactive Bladder Symptoms in Patients Recovering from Post-Acute COVID-19 Syndrome. November 6, 2022

Are β3 -adrenoceptor gene polymorphisms relevant for urology? November 6, 2022

The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder. October 30, 2022

Detailed Investigation of Bladder Diary Parameters During Sacral Neuromodulation in Patients With Overactive Symptoms. October 30, 2022

Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis. October 30, 2022

Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study. October 23, 2022

Treatment for overactive bladder: A meta-analysis of tibial versus parasacral neuromodulation. October 23, 2022

Compliance with Percutaneous Tibial Nerve Stimulation at a Tertiary Academic Center versus a County Hospital. October 23, 2022

Overactive bladder: not just a normal part of getting older. October 16, 2022

Relationship between marijuana use and Overactive Bladder (OAB): a cross-sectional research of National Health and Nutrition Examination Survey (NHANES) 2005 to 2018. October 16, 2022

Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study. October 16, 2022

Impact of mirabegron versus solifenacin on autonomic function and arterial stiffness in female overactive bladder syndrome: a randomized controlled trial. October 9, 2022

Clinical preferences and treatment attitudes among urologists, gynecologists, and geriatricians: An independent online questionnaire survey for comparison of treatment choices in the management of overactive bladder. October 9, 2022

Quality of life in patients with overactive bladder following botulinum toxin treatment: a preliminary report. October 9, 2022

A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder. October 2, 2022

Urinary Levels of miR-491-5p and miR-592 as Potential Diagnostic Biomarkers in Female Aging Patients with OAB: A Pilot Study. October 2, 2022

Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages. October 2, 2022

Page 18 of 122